AUTHOR=Jiang Yinyin , Chen Yaning , Li Dongfeng , Zhu Sha , Gu Ruxin , Wang Yaxi , Zhu Jun , Jiang Xu , Shen Bo , Pan Yang , Yan Jun , Zhang Li TITLE=Sleep structure and related clinical characteristics in drug-naïve Parkinson's disease with subjectively different sleep quality JOURNAL=Frontiers in Neurology VOLUME=Volume 14 - 2023 YEAR=2023 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1156910 DOI=10.3389/fneur.2023.1156910 ISSN=1664-2295 ABSTRACT=Abstract Background: Sleep disturbance is a common non-motor symptom in Parkinson’s disease (PD). Most polysomnography (PSG) studies are conducted when patients in their “on medication” state. Our study aimed to investigate changes in sleep structure in drug-naïve PD patients with poor subjective sleep quality based on polysomnography (PSG) and to explore potential correlations between sleep structure and clinical features of the disease. Methods: Forty-four drug-naïve PD patients were included. All patients completed a standardized questionnaire to obtain demographic and clinical characteristics and underwent whole-night PSG recording. Patients with PSQI scores >5.5 were considered to be poor sleepers and patients with PSQI scores <5.5 were considered to be good sleepers. Results: There were 24 (54.5%) PD patients in good sleeper group and 20 (24.5%) PD patients in poor sleeper group. We observed that poor sleepers had severer non-motor symptoms (NMS) and worse life quality. The PSG displayed that they had longer wake-up time after sleep onset (WASO) and lower sleep efficiency (SE). Correlation analysis revealed that micro-arousal index was positively associated with UPDRS-III and N1 sleep percentage was negatively associated with NMS score in good sleepers. For poor sleepers, rapid eye movement (REM) sleep percentage related negatively to Hoehn and Yahr (H&Y) stage, WASO increased with UPDRS-III, periodic limb movement index (PLMI) increased with NMS score, N2 sleep percentage related negatively to score of life quality. Conclusion: Night awakening is the main manifestation of decreased sleep quality in drug-naïve PD patients. Poor sleepers have severer non-motor symptoms and worse life quality. Additionally, the increase of nocturnal arousal events may predict progression of motor dysfunction.